Cargando...
Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patients
PURPOSE: This prospective clinical trial investigated sodium ((23)Na) MRI at 7 Tesla (T) field strength as biomarker for tumor extent, isocitrate dehydrogenase (IDH) mutation and O6-methylguanine DNA methyltransferase (MGMT) promotor methylation in glioma patients. METHODS: 28 glioma patients underw...
Gardado en:
| Publicado en: | Neuroimage Clin |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7527584/ https://ncbi.nlm.nih.gov/pubmed/33002860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nicl.2020.102427 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|